BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 [Yahoo! Finance]
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Yahoo! Finance
price target on GoodRx to $2.60 from $3 and kept an Underperform rating on the shares. For the broader drug distributor sector, however, the firm remained positive heading into 2026 and adjusted its price targets to align with recent changes in valuation multiples across the peer group. Additionally, Morgan Stanley reduced its price target for GoodRx from $5 to $4 while maintaining an Equal Weight rating on December 18. In a 2026 outlook for the Healthcare Services sector, the firm noted that while healthcare tech and providers offer an attractive backdrop for alpha-generation, the managed care segment continues to struggle. On December 8, Barclays initiated coverage of GoodRx with an Underweight rating and a $3 price target. While the firm established a Neutral outlook on the broader US healthcare tech and distribution industry, it expressed the most optimism toward drug distributors. In contrast, Barclays maintained a more cautious and mixed perspective on the dental and healthc
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- GoodRx (NASDAQ:GDRX) had its price target lowered by analysts at Citigroup Inc. from $5.00 to $4.50. They now have a "buy" rating on the stock.MarketBeat
- GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies [Yahoo! Finance]Yahoo! Finance
- GoodRx Launches RxSmartSaver at Giant Eagle PharmaciesBusiness Wire
- GoodRx (NASDAQ:GDRX) had its "reduce" rating reaffirmed by analysts at UBS Group AG.MarketBeat
- GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 11/4/25 - Beat
GDRX
Sec Filings
- 1/5/26 - Form 4
- 1/5/26 - Form 4
- 12/22/25 - Form 4
- GDRX's page on the SEC website